These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2764235)

  • 1. Incidence of amikacin ototoxicity: a sigmoid function of total drug exposure independent of plasma levels.
    Beaubien AR; Desjardins S; Ormsby E; Bayne A; Carrier K; Cauchy MJ; Henri R; Hodgen M; Salley J; St Pierre A
    Am J Otolaryngol; 1989; 10(4):234-43. PubMed ID: 2764235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicodynamics and toxicokinetics of amikacin in the guinea pig cochlea.
    Beaubien AR; Karpinski K; Ormsby E
    Hear Res; 1995 Mar; 83(1-2):62-79. PubMed ID: 7607992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration.
    Beaubien AR; Ormsby E; Bayne A; Carrier K; Crossfield G; Downes M; Henri R; Hodgen M
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1070-4. PubMed ID: 1929245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Ogier JM; Lockhart PJ; Burt RA
    Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs.
    Dirain CO; Ng MRAV; Milne-Davies B; Joseph JK; Antonelli PJ
    Otol Neurotol; 2018 Jan; 39(1):111-118. PubMed ID: 29194212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay in hearing loss following drug administration. A consistent feature of amikacin ototoxicity.
    Beaubien AR; Desjardins S; Ormsby E; Bayne A; Carrier K; Cauchy MJ; Henri R; Hodgen M; Salley J; St Pierre A
    Acta Otolaryngol; 1990; 109(5-6):345-52. PubMed ID: 2360443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
    Zadrożniak M; Szymański M; Łuszczki JJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
    Danhauer FJ; Fortner CL; Schimpff SC; deJongh CA; Wesley MN; Wiernik PH
    Clin Pharm; 1982; 1(6):539-43. PubMed ID: 7185540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of trimetazidine on amikacin-induced ototoxicity in rats.
    Aksoy F; Dogan R; Ozturan O; Eren SB; Veyseller B; Pektas A; Hüseyinbas Ö
    Int J Pediatr Otorhinolaryngol; 2014 Apr; 78(4):663-9. PubMed ID: 24582075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of ototoxicity of amikacin (BB-K8) by animal test (author's transl)].
    Akiyoshi M; Sato K; Nakada H; Tajima T; Suzuki K
    Jpn J Antibiot; 1975 Jun; 28(3):288-304. PubMed ID: 1152283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C alleviates ototoxic effect caused by coadministration of amikacin and furosemide.
    Zadrozniak M; Szymanski M; Luszczki JJ
    Pharmacol Rep; 2019 Apr; 71(2):351-356. PubMed ID: 30831441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of aminoglycoside ototoxicity by glutathione.
    Nishida I; Takumida M
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(2):68-73. PubMed ID: 8736049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients.
    Modongo C; Pasipanodya JG; Zetola NM; Williams SM; Sirugo G; Gumbo T
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6337-43. PubMed ID: 26248372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
    Murillo-Cuesta S; Contreras J; Cediel R; Varela-Nieto I
    Lab Anim; 2010 Apr; 44(2):124-31. PubMed ID: 19858169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-protection against aminoglycoside ototoxicity in guinea pigs.
    Oliveira JA; Canedo DM; Rossato M; Andrade MH
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):271-9. PubMed ID: 15365547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine's action against aminoglycoside-induced ototoxicity.
    Pavlidis P; Maurer J; Apostolidou E; Kekes G; Kouvelas D
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1491-6. PubMed ID: 23917735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside dosing regimen and pharmacokinetic parameters in the guinea pig.
    Dionisotti S; Bamonte F; Leung P; Kramer WG; Ongini E
    Chemotherapy; 1990; 36(1):33-40. PubMed ID: 2307023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of the otoprotective effect: how long does otoprotection against amikacin lasts?
    Oliveira AA; Campos Mde S; Murashima Ade A; Rossato M; Hyppolito MA; Oliveira JA
    Braz J Otorhinolaryngol; 2012 Dec; 78(6):47-50. PubMed ID: 23306567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.